José Ángel
García Pedraza
Profesor Permanente Laboral
Asunción
Morán Benito
Catedrática de Universidad
Publicaciones en las que colabora con Asunción Morán Benito (23)
2024
-
Chronic sarpogrelate treatment improves renal sympathetic hyperactivity in experimental diabetes
Biomedicine and Pharmacotherapy, Vol. 176
2023
-
Fármacos que actúan modulando la actividad enzimática
Fundamentos de farmacología básica y clínica (Editorial Médica Panamericana), pp. 101-112
-
Renal Sympathetic Hyperactivity in Diabetes Is Modulated by 5-HT1D Receptor Activation via NO Pathway
International Journal of Molecular Sciences, Vol. 24, Núm. 2
2022
-
Effect of sarpogrelate treatment on 5-HT modulation of vascular sympathetic innervation and platelet activity in diabetic rats
Biomedicine and Pharmacotherapy, Vol. 153
-
Fluoxetine Treatment Decreases Cardiac Vagal Input and Alters the Serotonergic Modulation of the Parasympathetic Outflow in Diabetic Rats
International Journal of Molecular Sciences, Vol. 23, Núm. 10
-
Oral fluoxetine treatment changes serotonergic sympatho-regulation in experimental type 1 diabetes
Life Sciences, Vol. 293
2021
-
Vascular sympathetic neurotransmission and its serotonergic regulation are modified by chronic fluoxetine treatment
Journal of Pharmacological Sciences, Vol. 147, Núm. 1, pp. 48-57
2020
-
Blockade of 5-HT2 receptors with sarpogrelate uncovers 5-HT7 receptors inhibiting the tachycardic sympathetic drive in pithed rats
Clinical and Experimental Pharmacology and Physiology, Vol. 47, Núm. 3, pp. 403-411
-
Dopamine D4 receptor subtype activation reduces the rat cardiac parasympathetic discharge
Pflugers Archiv European Journal of Physiology, Vol. 472, Núm. 12, pp. 1693-1703
-
Role of peripheral 5-HT5A receptors in 5-HT-induced cardiac sympatho-inhibition in type 1 diabetic rats
Scientific Reports, Vol. 10, Núm. 1
2019
-
Fluoxetine oral treatment discloses 5-HT 1D receptor as vagoinhibitor of the cardiac cholinergic neurotransmission in rat
Canadian Journal of Physiology and Pharmacology, Vol. 97, Núm. 2, pp. 90-98
-
Hypertension exhibits 5-HT 4 receptor as a modulator of sympathetic neurotransmission in the rat mesenteric vasculature
Hypertension Research, Vol. 42, Núm. 5, pp. 618-627
2018
-
Chronic 5-HT2 receptor blockade unmasks the role of 5-HT1F receptors in the inhibition of rat cardioaccelerator sympathetic outflow
Canadian Journal of Physiology and Pharmacology, Vol. 96, Núm. 4, pp. 328-336
2017
-
5-HT modulates the rat mesenteric vasopressor outflow by 5-HT1D sympatholytic receptors
Clinical and Experimental Pharmacology and Physiology, Vol. 44, Núm. 12, pp. 1224-1231
-
Chronic Sarpogrelate Treatment Reveals 5-HT7 Receptor in the Serotonergic Inhibition of the Rat Vagal Bradycardia
Journal of Cardiovascular Pharmacology, Vol. 69, Núm. 1, pp. 13-22
2016
-
5-HT2 receptor blockade exhibits 5-HT vasodilator effects via nitric oxide, prostacyclin and ATP-sensitive potassium channels in rat renal vasculature
Vascular Pharmacology, Vol. 79, pp. 51-59
-
Blocking 5-HT2 receptor restores cardiovascular disorders in type 1 experimental diabetes
Scientific Reports, Vol. 6
-
Pharmacological Evidence that Histamine H3 Receptors Mediate Histamine-Induced Inhibition of the Vagal Bradycardic Out-flow in Pithed Rats
Basic and Clinical Pharmacology and Toxicology, Vol. 118, Núm. 2, pp. 113-121
2015
-
5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats
Vascular Pharmacology, Vol. 72, pp. 172-180
-
Pharmacological evidence that 5-HT1D activation induces renal vasodilation by NO pathway in rats
Clinical and Experimental Pharmacology and Physiology, Vol. 42, Núm. 6, pp. 640-647